What Micropore Technologies Ltd. does

Micropore Technologies Ltd. is a UK-based process equipment company that develops and sells membrane-based particle engineering technology for the pharmaceutical and drug formulation industry. Its core technology uses patented membranes to produce emulsions, lipid nanoparticles (LNPs), liposomes, PLGA microspheres, and core/shell particle systems with no moving parts, enabling repeatable and reproducible manufacturing at lower energy consumption than traditional routes such as high-pressure homogenisation. The platform serves customers across R&D, pilot, and commercial manufacturing scales, targeting formulation challenges in nucleic acid therapeutics, vaccines, and advanced drug delivery.

The company sells capital equipment under a one-time licence/sales model through a direct enterprise sales motion, with regional contact lines covering Europe/Middle East/Asia and Americas/Canada. Its most recent product, HORIZON, was launched in April 2026 as a next-generation emulsification platform aimed at accelerating scale-up of complex drug formulations from laboratory to commercial production. The company is privately held, headquartered in Teesside, UK (Redcar), with an employee count in the 11-50 range, holds ISO 9001 certification, and operates without disclosed institutional funding, named customers, or partnerships.

The business is differentiated by its membrane-based architecture rather than competing on software, AI, or services. Its competitive moat rests primarily on patented intellectual property and process integration once a customer's formulation is qualified on the platform. The go-to-market is horizontal across multiple formulation applications, with no disclosed evidence of named enterprise customers, recurring revenue streams, or third-party validation, leaving customer concentration, revenue scale, and growth velocity largely opaque from the available data.

Name

Micropore Technologies Ltd.

Legal name

Micropore Technologies Ltd.

Website

https://micropore.co.uk

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

11–50 employees

Short description

Micropore Technologies Ltd. is a UK-based process equipment company that sells patented membrane-based particle engineering technology to pharmaceutical companies for manufacturing lipid nanoparticles, liposomes, PLGA microspheres, and emulsions across R&D, pilot, and commercial scales.

Ownership category

akta.pro rank

Product category

Pharmaceutical Processing Equipment

akta.pro primary industry

Crystallization, Particle Engineering & Micronization Services (HLAGAHAJ)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Delivery Systems & Encapsulation (Microencapsulation, Liposomes, Emulsions, Beadlets, Spray-Dried) (AFAJAKAL)

Keywords

• Membrane emulsification equipment
• Pharmaceutical particle engineering
• Lipid nanoparticle manufacturing
• Drug formulation technology
• Pharmaceutical processing equipment

Headquarters

HQ city

Redcar

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Particle engineering technology systems: Micropore sells its membrane-based particle engineering technology and equipment to pharmaceutical and drug formulation companies. The company serves the full lifecycle from R&D to pilot and commercial manufacturing, suggesting equipment/systems sales as the primary revenue stream.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Micropore Technologies Ltd. develops and supplies membrane-based particle engineering technology and equipment for the pharmaceutical and biotech industries. Its systems produce repeatable, reproducible emulsions and particles — including lipid nanoparticles, liposomes, PLGA microspheres, and core/shell systems — for drug formulation companies across R&D, pilot, and commercial manufacturing stages.

Product overview

Micropore Technologies Ltd. offers a membrane-based particle engineering platform for the pharmaceutical and biotech industries. The company's core technology enables repeatable, reproducible manufacturing of Lipid Nanoparticles (LNPs), Liposomes, PLGA Microspheres, Core/Shell Systems, and Emulsions. The platform accelerates formulation development from R&D through pilot to commercial-scale manufacturing, with key differentiators including reduced energy consumption, no moving parts for maintenance-free operation, and scalable production. The HORIZON platform represents their next-generation emulsification system for complex drug formulations.

Differentiator

Problem solved

Functional benefit

Products and services

• Membrane-Based Particle Engineering Technology Patented membrane-based mixing system that produces repeatable and reproducible particles and emulsions with no moving parts, reduced energy consumption, and minimal waste. Sold to pharmaceutical and drug formulation companies for R&D, pilot, and commercial manufacturing.
• HORIZON Emulsification Platform Next-generation membrane-based emulsification platform designed to accelerate scale-up of complex drug formulations from lab to commercial production, targeting pharmaceutical and drug development companies needing scalable particle manufacturing.

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/MicroporeTech

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Micropore Technologies Ltd.